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Background: The level of urine cotinine is an indicator of tobacco smoke exposure. The purpose of this study 
is to investigate urine cotinine for the purpose of assessing the smoking status of Korean smokers and non-smokers 
exposed to tobacco smoke.
Methods: The subjects were identified from the 2007-2009 and the 2010 data sets of the Korea National Health 
and Nutrition Examination Survey (KNHANES). They were assigned as non-smokers, current smokers and 
ex-smokers. Non-smokers were also divided into three subset groups according to the duration of smoke exposure. 
Each group was stratified by gender prior to analysis.
Results: The median value of urine cotinine in the male current smokers was 1,221.93 ng/mL which was the highest 
among all groups. The difference between levels of urine cotinine for male and the female groups was statistically 
significant (p＜0.01). In the female group, passive smoke exposure groups reported higher urine cotinine levels 
than non-exposure groups (p=0.01). The cutoff point for the discrimination of current smokers from non-smokers 
was 95.6 ng/mL in males and 96.8 ng/mL in females. The sensitivity and specificity were 95.2% and 97.1%, 
respectively, in males, 96.1% and 96.5% in females. However, the determination of urine cotinine level was not 
useful in distinguishing between passive smoke exposure groups and non-exposure groups.
Conclusion: Urine cotinine concentration is a useful biomarker for discriminating non-smokers from current smokers. 
However, careful interpretation is necessary for assessing passive smoke exposure by urine cotinine concentration.
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Introduction
  Smoking, which includes second-hand smoke, is a 
significant risk factor for various diseases such as can-
cers, respiratory diseases, heart problems and various 
forms of stroke1-3. It also contributes to the patients' 
death in most cases4. Therefore, exact assessments of 
the epidemiology of normal populations associated with 
current smoking status or second-hand smoke are im-
portant to control disease and set up public health poli-
cy4,5.
  Although there are many reports to investigate tobac-
co smoke exposure, most of assessments are based on 
self-reported questionnaires. However, there are some 
limitations in these measures because some respondents 
answer inaccurately about their smoking habits5-7. 
Wilcox et al.6 showed that true percentage of previous 
smokers who actually had quit smoking was between 
46% and 53% by biological marker studies. Therefore, 
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objective methods to estimate smoking status and sec-
ond-hand smoke exposure are needed.
  There are many toxic metabolites in tobacco, which 
have been suggested as biomarkers to assess tobacco 
smoke exposure. For example, thiocyanate, carbon 
monoxide, carboxyhemoglobin, hydroxyprolin and ar-
omatic amines can be used. However most of these bio-
markers have a low specificity and sensitivity because 
they are influenced by environmental factors8,9. There-
fore, they are not considered to good markers.
  Cotinine is major proximate metabolite of nicotine, 
which is oxidized in the liver by CYP2A6 and dis-
tributed in various body fluids including the blood, sali-
va and urine10. Moreover, cotinine has a much longer 
half-life (16 to 20 hours) than nicotine (2 hours)1,9 and 
presents higher concentrations in body fluids than nic-
otine11. Therefore, cotinine is considered a good bio-
marker to distinguish non-smokers from current smok-
ers12 and urinary cotinine is a preferred marker because 
urine can be obtained easily and non-invasively. How-
ever, Signorello et al.13 reported that urinary cotinine 
level was different for various ethnic backgrounds. In 
Korea, there are several studies about the usefulness of 
urinary cotinine to assess tobacco smoke exposure in 
a small number of subjects5,14. The purpose of this study 
is to investigate the role of urine cotinine for assessing 
the smoking status of people exposed to tobacco smoke 
in Korean based on large population study, Korea 
National Health and Nutrition Examination Survey 
(KNHANES) investigated from 2007 to 2010.
Materials and Methods
  In this study, we use the data set of KNHANES IV 
(2007∼2009) and the first year of KNHANES V (2010). 
The KNHANES is a nationwide survey that included 500 
survey areas drawn from the census populations and 
housing units by considering the proportion of each 
subgroup. This survey was executed by the Centers of 
Disease Control (CDC) of Korea to get statistically reli-
able and representative data, which include health, 
food, and lifestyle of the Korean population. Trained 
interviewers administered a questionnaire on the smok-
ing status and other health information. There were 9 
questions and 7 sub-questions about smoking and 
33,829 subjects answered those questions. Subjects' age 
was reclassified to 4 subsets (18∼24, 25∼44, 45∼64, 
and ≥65).
  Smoking status was divided to three groups: non- 
smokers, current smokers, and ex-smokers. Non-smok-
ers included both never smokers and smokers who had 
smoked under 100 cigarettes in their lifetime. Non- 
smokers were also divided to three groups according 
to their passive tobacco exposure time: non-exposure, 
exposure less an hour, and exposure over an hour per 
day groups. Tobacco smoke exposure was investigated 
at the working place and home. If subjects were ex-
posed to tobacco smoke for less an hour in both places, 
we assigned them as the exposures for over an hour 
group.
  On the other hand, we are able to assume that the 
urine cotinine concentration is higher in the men be-
cause a lot of men tend to smoke more than women. 
This hypothesis suggests the cutoff value to distinguish 
smokers from non-smokers can be different between 
men and women. Therefore each group was stratified 
by gender before analysis.
  There were 33,829 subjects who replied on their 
smoking-related questions. According to the above cri-
teria, 14,315 (42.3%), 4,973 (14.7%), and 3,088 (9.1%) 
subjects were assigned to the non-smokers, current 
smokers, and ex-smokers, respectively. In the same 
way, 14,315 subjects who answered the questionnaires, 
the subjects with non-exposure, exposure for less an 
hour, and over an hour group were assigned to 159 
(1.1%), 770 (5.4%), and 1,673 (11.7%) persons, respec-
tively.
  Urine cotinine level was measured by gas chromatog-
raphy mass spectrometry using the Perkin Elmer Clarus 
600T (PerkinElmer, Turku, Finland). All data were 
measured in a standardized manner and reviewed by 
central quality control center.
  All statistical analyses were performed with SAS ver-
sion 9.2 (SAS Institute Inc., Cary, NC, USA). The differ-
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Table 1. Characteristics of subjects stratified by smoking status
Non-smoker Current smoker Ex-smoker p-value
Sex, n (%)
  Male  2,151 (15.03)   4,237 (85.20) 2,646 (85.69)
  Female 12,164 (84.97)    736 (14.80)  442 (14.31)
Age, mean±SD, n (%)
  18∼24   816 (6.25)    259 (5.71)   61 (2.16)
  25∼44  4,776 (36.59)   2,154 (47.53)  800 (28.27)
  45∼64  4,536 (34.75)   1,449 (31.97) 1,024 (36.18)
  ≥65  2,925 (22.41)    670 (14.78)  945 (33.39)
Cotinine, median value (IQR)*, ng/mL
  Male   5.31 (14.59) 1,221.93 (1,257.00)  8.14 (23.71) ＜0.01
  Female   4.49 (14.93)  822.93 (926.80)  7.83 (38.35) ＜0.01
*Urine cotinine is expressed median value (IQR) because it does not follow a normal distribution.
n: a total number of subjects; SD: standard deviation; Cotinine: level of urine cotinine; IQR: interquartile range.
Table 2. Duration of daily passive smoke exposure among non-smokers
None Less an hour Over an hour p-value
Sex, n (%)
  Male  18 (11.32)   40 (5.19)  240 (14.35)
  Female 141 (88.68)  730 (94.81) 1,433 (85.65)
Age, mean±SD (%)
  18∼24  10 (6.85)   46 (6.55)   61 (2.16)
  25∼44  58 (39.73)  261 (37.18)  594 (39.23)
  45∼64  52 (35.62)  257 (36.61)  641 (42.34)
  ≥65  26 (17.81)  138 (19.66)  139 (9.18)
Cotinine, median value (IQR)*, ng/mL
  Male 3.83 (9.83) 12.76 (15.59) 10.56 (31.54) 0.12
  Female 7.07 (18.21) 48.50 (22.55) 10.06 (27.63) 0.01
*Urine cotinine is expressed median value (IQR) because it does not follow normal distribution.
n: a total number of subjects; SD: standard deviation; Cotinine: level of urine cotinine; IQR: interquartile range.
ence of urine cotinine level between each group was 
analyzed by the Kruskal-Wallis test because the level of 
urine cotinine did not follow a normal distribution. The 
statistical significance was considered by the p-value of 
less than 0.05. Logistic regression analysis and receiver 
operating characteristic (ROC) curve estimated the cutoff 
point to discrinimate between current smokers and 
non-smokers. The cutoff point was determined by 
Youden method.
Results
  There were 9,034 men (40.4%) and 13,342 women 
(59.6%) in the final study population. Current smokers 
and ex-smokers were predominant in the male pop-
ulation−85.2% and 85.7%, respectively. The portions 
of non-smokers were much higher (85.0%) in the 
female. The mean age was 48.9 (±16.6). The age of 
most subjects was between 25 and 64. Urine cotinine 
level ranged from 0.009 ng/mL to 7,817.46 ng/mL. The 
median value of urine cotinine was highest in the cur-
rent smokers (1,177.39 ng/mL). Men had higher coti-
nine level than women in all three groups. The median 
value and interquartile range of blood urea nitrogen and 
creatinine were similar in all groups. Other character-
istics are summarized in Table 1.
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Figure 1. (A, B) Median values for urine cotinine among non-smokers, current smokers and ex-smokers.
Figure 2. (A, B) Median values for urine cotinine between non-exposure and passive exposure status in non-smokers.
  Two thousand and six hundred two subjects of the 
14,315 non-smokers replied with their tobacco smoke 
exposure rate. A higher rate of smoke exposure was 
observed in females for both less an hour and over an 
hour exposure groups. The median value of urine coti-
nine was highest in the tobacco smoke exposure over 
an hour groups, 10.22 ng/mL. These details are in Table 
2.
  The median value of urine cotinine was significantly 
different among the groups sorted by smoking status (p
＜0.01). In the analysis of the subgroups divided ac-
cording to the gender, all groups had shown statistical 
distinction (p＜0.01). The current smokers had higher 
level of urine cotinine compared with that of the other 
groups (Table 1, Figure 1).
  Among the non-smokers, we found that the duration 
of tobacco smoke exposure could be possible to attrib-
ute to the level of urine cotinine (p＜0.01). However, 
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Figure 3. The receiver operating characteristic (ROC) curves of urine cotinine for determining the cutoff value used to
distinguish between current smokers and non-smokers. (A) The curve represents the male group and (B) the curve 
represents the female group.
Table 3. The cutoff values of urine cotinine used to dis-
tinguish non-smokers from smokers







Male 95.5  95.2 97.1
  FPR* 2.9 (71/2,476)
  FNR† 4.8 (60/1,259)
Female 96.8  96.1 96.5
  FPR 3.5 (13/370)
  FNR 3.9 (232/5,920)
*FPR expressed rate (total subjects with less cutoff/true smok-
ers). †FNR expressed rate (total subjects with over cutoff/true 
non-smokers).
FPR: false positive rate; FNR: false negative rate.
Table 4. The cutoff values of urine cotinine used to dis-
tinguish ex-smokers from smokers







Male  94.2 96.5 90.6
  FPR* 6.7 (173/2,578)
  FNR† 4.7 (71/1,528)
Female  91.5 95.4 85.3
  FPR 9.4 (37/394)
  FNR 6.3 (13/208)
*FPR expressed rate (total subjects with less cutoff/true smok-
ers). †FNR expressed rate (total subjects with over cutoff/true
non-smokers)
FPR: false positive rate; FNR: false negative rate.
the duration of passive smoke exposure could not show 
the difference of urine cotinine level in the men 
(p=0.20). The level of urine cotinine of tobacco smoke 
exposure in the over an hour groups was higher com-
pared with that of the other groups (Table 2, Figure 2).
  To set the cutoff value to distinguish between non- 
smokers and current smokers, we used ROC curves. 
Area under the curve (AUC) of the ROC curves revealed 
0.981 in the male subgroups, therefore the level of urine 
cotinine was considered a valuable marker for discrim-
ination (Figure 3A). The 95.5 ng/mL of cutoff value 
showed 95.2% of sensitivity and 97.1% of specificity 
(Table 3). In the female subgroups, urine cotinine was 
a reliable marker to determine whether female subjects 
were smokers or not because the value of AUC was 
0.979 (Figure 3B). The cutoff point was 96.8 ng/mL 
with 96.1% of sensitivity and 96.5% of specificity (Table 
3).
  In addition to this result, we excuted same analysis 
between ex-smokers and current smokers. We obtained 
the similar result and those were presented on Table 
4 and Figure 4. However the ROC curve drawn with 
non-smokers and ex-smokers did not show usefulness 
to get cutoff value to seperate them (Figure 5).
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Figure 4. The receiver operating characteristic (ROC) curves of urine cotinine for finding cutoff value to distinguish current
smokers from ex-smokers. (A) The curve represents the male group and (B) the curve represents the female group.
Figure 5. The receiver operating characteristic (ROC) curves of urine cotinine for determining the cutoff value used to
distinguish ex-smokers from non-smokers. (A) The curve represents the male group and (B) the curve represents the
female group.
  In the analysis of non-smokers to distinguish passive 
exposure groups from non-exposure groups, the level 
of urine cotinine was not statistically significance. The 
AUC was 0.667 in the male non-smokers and 0.562 in 
the female non-smokers (Figure 6). Therefore, the cut-
off point of urine cotinine to discriminate passive smoke 
exposure from non-exposure was invalid.
Discussion
  In this study, we found that the level of urine cotinine 
was higher in the men compared with that of women. 
The difference of urine cotinine between smokers and 
non-smokers was statistically significant (p＜0.01 both 
in the male and female groups). Therefore urine coti-
nine level could be a good marker to distinguish current 
smokers from non-smokers both male and female 
groups. The cutoff value of urine cotinine to determine 
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Figure 6. The receiver operating characteristic (ROC) curves of urine cotinine for determining the cutoff value used to
distinguish non-exposure groups from passive smoking exposure groups. (A) The curve represents the male group and
(B) the curve represents the female group.
whether the one is smoker is 95.5 ng/mL for males and 
96.8 ng/mL for females. These values were detemined 
by ROC curve analysis with Youden method. Similarly 
94.2 ng/mL in the men and 91.5 ng/mL in the female 
will be used to cutoff value to distinguish current smok-
ers from ex-smokers. This results appropriated pre-
viously mentioned hypothesis that men had higher urine 
cotinine level compared with women because men 
smoked much more then women and cutoff value 
would be different between men and women.
  However, urine cotinine was not able to discriminate 
neither ex-smokers nor passive smokers from non- 
smokers. These results could be explained with half life 
of cotinine. Because the half life of cotinine is less than 
24 hours, we cannot detect higher level of cotinine from 
ex-smokers who quit tobacco recently.
  Wall et al.15 reported that urine cotinine level was 
higher in smokers than non-smokers, and tended to in-
crease to the total amount of smoke exposure propor-
tionally in their study with 98 subjects. However, he did 
not propose a cutoff value to distinguish between each 
other. Vine et al.16 also showed similar results in their 
study with 88 subjects. Urine cotinine level was higher 
compared with that of any other body fluids and raised 
with an increase of tobacco smoke exposure16. Jee et 
al.14 investigated 99 high school students and concluded 
that the cotinine level correlated with smoke exposure, 
and suspected that urine cotinine level could reflect 
chronic exposure of cigarettes.
  Jarvis et al.7 presented the cutoff value of urine coti-
nine to discriminate between true smokers and non- 
smokers as 49.7 ng/mL with 97% of sensitivity and 99% 
of specificity. In addition, they concluded that cotinine 
provided the best results of discrimination and urine co-
tinine could be used clinically7. Haufroid and Lison9 
suggested the discrimination threshold of urine cotinine 
between active and passive smokers to be between 20 
to 100 ng/mL because non-smokers' urine cotinine level 
did not exceed 100 ng/mL in several studies. Zielińska- 
Danch et al.17 recommended that the cutoff level of 
urine cotinine to be 550 ng/mL to discriminate non- 
smokers from current smokers. Furthermore, the level 
of 170 ng/mL could distinguish non-exposure groups 
and light smoke exposure groups from heavy smoke ex-
posure groups. Finally, urine cotinine level of less than 
50 ng/mL could determine non-smoke exposure17.
  In this study, we reported the cutoff value of 95.5 
ng/mL in the men and 96.8 ng/mL in the women. This 
is higher level of urine cotinine compared with which 
was investigated previously. Because the urine cotinine 
level has racial variation13, we can assume that the urine 
cotinine level in the Korean smokers can be different 
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from those of other studies.
  Kwon et al.18 said that the cotinine formation from 
the nicotine was related to genetic polymorphism of cy-
tochrome P450 (CYP) 2A6. According to those reports, 
Koreans tended to have higher cotinine level than that 
of the Japanese because of higher allele frequencies of 
CYP 2A6*1A, CYP2A6*1B. Although most Asians had 
similar allele frequencies of CYP 2A6, the Caucasians 
showed higher allele frequencies which decreased the 
metabolic rate of nicotine18. This can be the reason why 
our study shows a higher cutoff value compared to that 
of other studies.
  In addition, the different methods to measure urine 
cotinine were used in each research. As mentioned ear-
iler, we used gas chromatography mass spectrometry 
using the Perkin Elmer Clarus 600T. Although Jarvis et 
al.7 used gas chromatography without adjustment urine 
flow, Haufroid and Lison9 measured urine cotinine level 
with colorimetric methods and Zielinska-Danch et al.17 
used liquid chromatography modified by Nakazima who 
was Japanese researcher19. Therefore these differences 
could be possible causes of that result.
  Our study has some limitations. First, our data from 
KNHANES were based on self-reported surveys. There-
fore it is possible that current smokers say that they are 
non-smokers and vice versa. Kang et al.5 contacted peo-
ple who reported being non-smokers but who had high 
urine cotinine level again about their smoking status 
and could verify true non-smokers and heavy passive 
smokers. Contrary to this, we were not able to re-check 
the smoking status too large sample size among non- 
smokers whose urine cotinine level was high. Second, 
a few people reported using nicotine replacement ther-
apy to quit tobacco smoking. These people could have 
elevated cotinine level because of continous supply of 
nicotine.
  However, this study was based on large population 
compared with the other studies in Korean. Therefore 
we can generalize the results. If we reset the cutoff val-
ue of urine cotinine 41 ng/mL in the men, we can ob-
tain 90.5% of sensitivity and 98.6% of specificity. 
Likewise the cutoff value of 300 ng/mL will give us 
96.9% of sensitivity and 90.1% of specificity in the male 
groups. This means people can modify the cutoff value 
on their purpose. In other words, we can use higher 
cutoff value up to 300 ng/mL to maximize sensitivity. 
This value can be used to distinguish non-smokers from 
smokers to give advantages to non-smokes. In contrast, 
the lower cutoff value near 41 ng/mL will be used to 
maximize specificity and can be used to anti-smoking 
clinic to discriminate current smokers from who stop 
smoking. However, we failed to show the usefulness 
of urine cotinine level to discriminate non-exposure 
from passive smoke exposure among non-smokers. 
This result is similar to those of Lee et al.20 and 
Caraballo et al.21.
  In conclusion, urine cotinine is a useful biomarker to 
discriminate current smokers from non-smokers. The 
cutoff value to discriminate current smokers from non- 
smokers will be modified by the aim of distinguish. 
More studies are needed to find out biomarkers to dis-
tinguish passive smoke exposure.
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